FDA approves focused ultrasound for TTTS by Q4 2027
Resolves: FDA issues a formal approval letter for the focused ultrasound TTTS treatment device.
user-generated· regulatory
FDA approves focused ultrasound for TTTS by Q4 2027
Market overview
The FDA grants 510(k) clearance for the Queen Charlotte's Hospital TTTS ultrasound treatment after Phase II trials confirm safety and efficacy in 80% of treated cases. Authorization would enable U.S. adoption starting in early 2028.
regulatory prediction market
- Implied probability (Yes)
- 60%
- Closes
- 2027-12-31
About this prediction
Resolution criteria
FDA issues a formal approval letter for the focused ultrasound TTTS treatment device.
Source: user-generated
More regulatory markets
- Crypto billionaire Harborne faces FCA scrutiny over £5m gift — 55% Yes
- Crypto billionaire Harborne will face FCA scrutiny — 60% Yes
- Crypto billionaire Christopher Harborne’s donation triggers FCA inquiry into funding transparency — 70% Yes
- Crypto billionaire Christopher Harborne will face parliamentary scrutiny over £5m gift — 55% Yes
- Harborne crypto holdings face regulatory scrutiny — 60% Yes
- SEC approves at least 2 new Bitcoin ETFs by Q4 2027 — 75% Yes
- SEC approves Kalshi's crypto futures products by 2026-Q3 — 55% Yes
- Iran's central bank bans crypto mining by 2027 Q1 — 85% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…